Rel-tert-butyl (2R,3R)-3-hydroxy-2-methylpiperidine-1-carboxylate

Catalog No. :
ACVTCM182
CAS No. :
2091703-25-0
Molecular Formula :
C11H21NO3
Molecular Weight :
215.29

IUPAC Name:tert-butyl (2R,3R)-3-hydroxy-2-methylpiperidine-1-carboxylate

Rel-tert-butyl (2R,3R)-3-hydroxy-2-methylpiperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$234.00Login to see priceIn stockInquiry
250mg97%$375.00Login to see priceIn stockInquiry
500mg97%$624.00Login to see priceIn stockInquiry
1g97%$934.00Login to see priceIn stockInquiry
5g97%$2802.00Login to see priceIn stockInquiry
10g97%$4762.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRel-tert-butyl (2R,3R)-3-hydroxy-2-methylpiperidine-1-carboxylate
IUPAC Nametert-butyl (2R,3R)-3-hydroxy-2-methylpiperidine-1-carboxylate
MDL No.MFCD30737567
Molecular FormulaC11H21NO3
Molecular Weight215.29
SMILESO=C(N1[C@H](C)[C@H](O)CCC1)OC(C)(C)C
InChI KeyADVNLLSPFSWKPK-RKDXNWHRSA-N
Synonym2091703-25-0 | tert-butyl (2R,3R)-3-hydroxy-2-methylpiperidine-1-carboxylate | Rel-tert-butyl (2R,3R)-3-hydroxy-2-methylpiperidine-1-carboxylate | starbld0045883 | SCHEMBL2913442 | AKOS034820026 | EN300-386265 | Z2828146549 | rac-tert-butyl (2R,3R)-3-hydr
CAS No.2091703-25-0
PubChem CID68438748

Synthetic Route by SureRoute

1. ACVTCM182 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVTCM182 route product structure diagram
    ACVTCM1822091703-25-0 In Stock
Inquiry

2. ACVTCM182 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVTCM182 route product structure diagram
    ACVTCM1822091703-25-0 In Stock
Inquiry

Comments (0)